Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii

Citation
P. Periti et F. Tonelli, Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii, J CHEMOTHER, 13(5), 2001, pp. 473-493
Citations number
146
Categorie Soggetti
Pharmacology
Journal title
JOURNAL OF CHEMOTHERAPY
ISSN journal
1120009X → ACNP
Volume
13
Issue
5
Year of publication
2001
Pages
473 - 493
Database
ISI
SICI code
1120-009X(200110)13:5<473:PACPOB>2.0.ZU;2-E
Abstract
Probiotic agents are living microorganisms that, upon ingestion, exert heal th benefits beyond inherent general nutrition. In this context, we must dif ferentiate between biotherapeutics as approved drugs and dietary supplement s and food products containing probiotic bacteria that are not considered d rugs. At present the only biotherapeutic agent which is prescribable in som e European countries, indicated to relieve specific diseases, is the yeast Saccharomyces, boulardii. In this review we consider the various preclinical and clinical aspects of biotherapeutics as basic drugs and the biotherapeutic powers of their use i n the treatment of some surgical enteropathies.